Compare Stocks → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:BMNCVE:EMH Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMNBlackrock 2037 Municipal Target Term Trust$23.87-0.2%$23.98$21.51▼$25.59N/AN/A22,716 shs17,565 shsEMHEmerald Health TherapeuticsC$0.26-3.8%C$0.26C$0.15▼C$0.53C$52.28MN/A644,760 shs384,329 shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMNBlackrock 2037 Municipal Target Term Trust-0.13%+0.34%-1.20%+2,390,999,900.00%+2,390,999,900.00%EMHEmerald Health Therapeutics0.00%0.00%0.00%0.00%0.00%Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AN/AN/AN/AN/AN/AEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AN/AEMHEmerald Health TherapeuticsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBMNBlackrock 2037 Municipal Target Term Trust$11.91MN/AN/AN/AN/AN/AEMHEmerald Health TherapeuticsC$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBMNBlackrock 2037 Municipal Target Term TrustN/AN/A0.00∞N/AN/AN/AN/AN/AEMHEmerald Health TherapeuticsN/A-C$0.70N/A∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBMNBlackrock 2037 Municipal Target Term Trust$1.124.69%N/AN/A1 YearsEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/ALatest BMN, EMH, BKY, and RBW DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/1/2024BMNBlackrock 2037 Municipal Target Term TrustMonthly$0.09404.68%4/12/20244/15/20245/1/20243/1/2024BMNBlackrock 2037 Municipal Target Term TrustMonthly$0.09404.72%3/14/20243/15/20244/1/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AEMHEmerald Health Therapeutics35.452.972.61OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBMNBlackrock 2037 Municipal Target Term TrustN/AEMHEmerald Health TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipBMNBlackrock 2037 Municipal Target Term TrustN/AEMHEmerald Health TherapeuticsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AN/AEMHEmerald Health Therapeutics161205.03 millionN/ANot OptionableBMN, EMH, BKY, and RBW HeadlinesSourceHeadlineUniversity Hospitals Elyria Medical Centerhealth.usnews.com - September 23 at 12:26 AMDigital Therapeutics: Next wave in managing chronic medical conditionshealth.economictimes.indiatimes.com - September 13 at 9:19 PMThe Digital Therapeutics Market Is Gangbustersmddionline.com - August 29 at 11:45 PMDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce Studyfinance.yahoo.com - July 31 at 12:17 AMEmerald Isle’s Lee Avenue to close again soon as culvert project restartscarolinacoastonline.com - July 15 at 8:44 AMEfficient Market Hypothesis (EMH): Definition and Critiqueinvestopedia.com - July 12 at 2:56 PMRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solutionfinance.yahoo.com - June 20 at 12:36 PMMenarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023thaipr.net - May 29 at 4:23 AMEmerald Care Center Tulsahealth.usnews.com - May 4 at 11:26 PMEmerald Reeghealth.usnews.com - April 25 at 7:35 AMEmerald Expositions GAAP EPS of $0.06, revenue of $93.6Mmsn.com - March 14 at 9:07 AMTahoe's Emerald Bay freezes over for first time in decades amid atmospheric riversfgate.com - March 13 at 4:02 AMVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conferenceventurebeat.com - March 4 at 6:25 PMEmerald community raising money for local dialysis services after political campaigns failabc.net.au - February 25 at 12:07 AMNew Digital Therapeutics Company Takes a 'Swing' at Fibromyalgiamddionline.com - February 22 at 11:25 PMEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Yearfinance.yahoo.com - January 14 at 1:43 PMEmerald Health Therapeutics Inc (TBD.BE)finance.yahoo.com - January 4 at 3:42 AMEmerald Health Therapeutics Announces Revocation of Management Cease Trade Orderfinance.yahoo.com - July 12 at 9:36 AMEmerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Updatefinance.dailyherald.com - July 4 at 7:56 AMEmerald Health Therapeutics Provides Bi-Weekly MCTO Status Updatefinance.yahoo.com - June 16 at 8:02 AMEmerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Updatestockhouse.com - May 16 at 4:37 PMSkye Bioscience Signs Arrangement Agreement with Emerald Health Therapeuticsnz.finance.yahoo.com - May 12 at 9:26 AMCannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQBinvestorideas.com - May 6 at 10:47 AMEmperor Oil Ltd (EMh)investing.com - January 5 at 8:00 AMMedia Sentiment Over TimeCompany DescriptionsBlackrock 2037 Municipal Target Term TrustNYSE:BMNBlackrock 2037 Municipal Target Term Trust is an close-ended fixed income mutual fund launched by Blackrock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in fixed income markets. The fund primarily invests in n investment grade municipal securities that are rated BBB- or above by S&P and Fitch or Baa3 or above by Moody's. Blackrock 2037 Municipal Target Term Trust is domiciled in the United States.Emerald Health TherapeuticsCVE:EMHEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
